Pathway Financial Advisers’s Westlake Chemical Partners WLKP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4M Buy
107,894
+1,296
+1% +$29.5K 0.61% 61
2026
Q1
$2.35M Buy
106,598
+3,221
+3% +$69.1K 0.67% 56
2025
Q4
$1.96M Sell
103,377
-3,800
-4% -$73.4K 0.57% 63
2025
Q3
$2.25M Buy
107,177
+1,270
+1% +$27.8K 0.66% 54
2025
Q2
$2.34M Buy
105,907
+2,517
+2% +$57K 0.76% 46
2025
Q1
$2.39M Buy
103,390
+1,610
+2% +$38.3K 0.82% 40
2024
Q4
$2.36M Buy
101,780
+97,339
+2,192% +$2.23M 0.79% 42
2024
Q3
$99.5K Sell
4,441
-93,472
-95% -$2.12M 0.05% 145
2024
Q2
$2.21M Buy
97,913
+221
+0.2% +$4.92K 0.79% 40
2024
Q1
$2.17M Buy
97,692
+1,532
+2% +$34.4K 0.78% 42
2023
Q4
$2.08M Sell
96,160
-1,888
-2% -$41.1K 0.79% 40
2023
Q3
$2.13M Buy
+98,048
New +$2.19M 0.88% 38
2023
Q1
$1.95M Buy
88,431
+39,322
+80% +$922K 0.78% 45
2022
Q4
$1.15M Buy
+49,109
New +$1.11M 0.47% 70

Other funds holding WLKP

Pathway Financial Advisers's WLKP Position: Q2 2026 in Review

Pathway Financial Advisers increased its Westlake Chemical Partners (WLKP) stake by 1.2% in Q2 2026, buying an estimated $29.5K and bringing the position to 107,894 shares worth $2.4M. The position accounts for 0.61% of the portfolio, ranked #61.

Pathway Financial Advisers first reported a position in WLKP in Q4 2022 and has held it in 14 quarters since. 56 funds tracked by Wall St. Rank hold WLKP as of Q2 2026.

  • Pathway Financial Advisers held 107,894 shares of Westlake Chemical Partners worth $2.4M as of Q2 2026.
  • Pathway Financial Advisers bought 1,296 Westlake Chemical Partners shares in Q2 2026, an estimated $29.5K.
  • Westlake Chemical Partners made up 0.61% of Pathway Financial Advisers's portfolio in Q2 2026, its #61 holding.
  • Pathway Financial Advisers first reported a position in Westlake Chemical Partners in Q4 2022 and has held it in 14 quarters since.
  • 56 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q2 2026.

Based on Pathway Financial Advisers's 13F filing for Q2 2026, filed 30 Jul 2026.